Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression
Opening soon NCT07581288
Run by University of British Columbia · for 35 and older · Women
What this study is about
The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.
Who can join (things the study team will check)
✅ You may be able to join if…
- 35 years and older
- Have experienced AUB
🚫 You may not be able to join if…
- Currently pregnant or become pregnant during their participation
- Previous surgeries impairing the menstrual cycle (e.g. hysterectomy, bilateral oophorectomy)
- Currently or in the previous 3 months on medications that are known to impair or stimulate ovulation (e.g. oral contraceptives, ovulation stimulants, hormone replacement, etc.)
Where this trial is running
- Vancouver General Hospital Research Pavillion, Vancouver, British Columbia, Canada
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.